RYTNX vs. RYOIX

Last updated Jun 3, 2026

RYTNX (Rydex S&P 500 2x Strategy Fund) and RYOIX (Rydex Biotechnology Fund) are both mutual funds - RYTNX is a Leveraged Equities fund managed by Rydex Funds, while RYOIX is a Health & Biotech Equities fund managed by Rydex Funds. Over the past 10 years, RYTNX returned 22.93%/yr vs 8.70%/yr for RYOIX. A 0.67 correlation means they provide meaningful diversification when combined. RYTNX charges 1.82%/yr vs 1.36%/yr for RYOIX.

Performance

RYTNX vs. RYOIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rydex S&P 500 2x Strategy Fund (RYTNX) and Rydex Biotechnology Fund (RYOIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RYTNX achieves a 20.21% return, which is significantly higher than RYOIX's 5.72% return. Over the past 10 years, RYTNX has outperformed RYOIX with an annualized return of 22.93%, while RYOIX has yielded a comparatively lower 8.70% annualized return.

RYTNX

• 1D: 0.51%
• 1M: 10.11%
• YTD: 20.21%
• 6M: 20.19%
• 1Y: 54.37%
• 3Y*: 36.65%
• 5Y*: 18.55%
• 10Y*: 22.93%

RYOIX

• 1D: -2.02%
• 1M: 3.61%
• YTD: 5.72%
• 6M: 6.19%
• 1Y: 42.41%
• 3Y*: 13.62%
• 5Y*: 5.46%
• 10Y*: 8.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RYTNX vs. RYOIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RYTNX Rydex S&P 500 2x Strategy Fund	20.21%	24.88%	41.95%	45.20%	-39.32%	55.55%	20.31%	62.29%	-15.06%	42.95%
RYOIX Rydex Biotechnology Fund	5.72%	30.62%	-0.95%	6.06%	-13.04%	2.05%	21.94%	30.69%	-8.94%	29.68%

Correlation

The correlation between RYTNX and RYOIX is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.50
Correlation (3Y) Calculated over the trailing 3-year period	0.55
Correlation (5Y) Calculated over the trailing 5-year period	0.61
Correlation (10Y) Calculated over the trailing 10-year period	0.63
Correlation (All Time) Calculated using the full available price history since Jan 3, 2001	0.67

The correlation between RYTNX and RYOIX shifts across timeframes, from 0.50 (1 year) to 0.67 (all time), reflecting how their relationship changes across market environments.

Return for Risk

RYTNX vs. RYOIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RYTNX

RYTNX Risk / Return Rank: 59
RYTNX Sharpe Ratio Rank: 64
RYTNX Sortino Ratio Rank: 50
RYTNX Omega Ratio Rank: 51
RYTNX Calmar Ratio Rank: 61
RYTNX Martin Ratio Rank: 68

RYOIX

RYOIX Risk / Return Rank: 72
RYOIX Sharpe Ratio Rank: 63
RYOIX Sortino Ratio Rank: 64
RYOIX Omega Ratio Rank: 51
RYOIX Calmar Ratio Rank: 93
RYOIX Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RYTNX vs. RYOIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rydex S&P 500 2x Strategy Fund (RYTNX) and Rydex Biotechnology Fund (RYOIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RYTNX	RYOIX	Difference
Sharpe ratio Return per unit of total volatility	2.36	2.34	+0.02
Sortino ratio Return per unit of downside risk	2.98	3.35	-0.37
Omega ratio Gain probability vs. loss probability	1.39	1.39	0.00
Calmar ratio Return relative to maximum drawdown	3.02	5.09	-2.07
Martin ratio Return relative to average drawdown	13.24	18.46	-5.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RYTNX vs. RYOIX - Sharpe Ratio Comparison

The current RYTNX Sharpe Ratio is 2.36, which is comparable to the RYOIX Sharpe Ratio of 2.34. The chart below compares the historical Sharpe Ratios of RYTNX and RYOIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RYTNX	RYOIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.36	2.34	+0.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.55	0.26	+0.29
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.64	0.38	+0.26
Sharpe Ratio (All Time) Calculated using the full available price history	0.25	0.36	-0.11

Drawdowns

RYTNX vs. RYOIX - Drawdown Comparison

The maximum RYTNX drawdown since its inception was -86.64%, which is greater than RYOIX's maximum drawdown of -74.43%. Use the drawdown chart below to compare losses from any high point for RYTNX and RYOIX.

Drawdown Indicators

	RYTNX	RYOIX	Difference
Max Drawdown Largest peak-to-trough decline	-86.64%	-74.43%	-12.21%
Max Drawdown (1Y) Largest decline over 1 year	-18.43%	-8.43%	-10.00%
Max Drawdown (3Y) Largest decline over 3 years	-35.36%	-23.47%	-11.89%
Max Drawdown (5Y) Largest decline over 5 years	-47.01%	-33.66%	-13.35%
Max Drawdown (10Y) Largest decline over 10 years	-59.23%	-33.66%	-25.57%
Current Drawdown Current decline from peak	0.00%	-2.03%	+2.03%
Average Drawdown Average peak-to-trough decline	-28.54%	-27.65%	-0.89%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.20%	2.32%	+1.88%

Volatility

RYTNX vs. RYOIX - Volatility Comparison

The current volatility for Rydex S&P 500 2x Strategy Fund (RYTNX) is 5.62%, while Rydex Biotechnology Fund (RYOIX) has a volatility of 6.11%. This indicates that RYTNX experiences smaller price fluctuations and is considered to be less risky than RYOIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RYTNX	RYOIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.62%	6.11%	-0.49%
Volatility (6M) Calculated over the trailing 6-month period	17.93%	14.61%	+3.32%
Volatility (1Y) Calculated over the trailing 1-year period	23.73%	19.21%	+4.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	33.75%	21.19%	+12.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.16%	23.22%	+12.94%

RYTNX vs. RYOIX - Expense Ratio Comparison

RYTNX has a 1.82% expense ratio, which is higher than RYOIX's 1.36% expense ratio.

Dividends

RYTNX vs. RYOIX - Dividend Comparison

RYTNX's dividend yield for the trailing twelve months is around 3.98%, less than RYOIX's 11.89% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RYOIX Rydex Biotechnology Fund	11.89%	12.57%	14.61%	0.00%	1.29%	19.39%	7.28%	8.58%	14.11%	5.38%	0.00%	1.45%
RYTNX Rydex S&P 500 2x Strategy Fund	3.98%	4.79%	5.45%	0.14%	0.00%	0.14%	0.69%	1.84%	0.00%	5.84%	0.16%	1.52%

Frequently Asked Questions

Can I hold both RYTNX and RYOIX in my portfolio?

RYTNX and RYOIX have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RYTNX or RYOIX?

RYOIX has higher volatility (6.11%) compared to RYTNX (5.62%). In terms of maximum drawdown, RYTNX dropped -86.64% vs RYOIX's -74.43%.

Which has better risk-adjusted returns?

RYTNX currently has the higher Sharpe Ratio (2.36 vs 2.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.